Discontinued Operations

9 Months Ended

Sep. 30, 2013

Discontinued Operations And Disposal Groups [Abstract]

Discontinued Operations

Note 6—Discontinued Operations

On August 31, 2012, the Company sold all of the shares of common stock of Agera held by the Company, which represented 57% of the outstanding common stock of Agera to Rohto Pharmaceutical Co., Ltd. for approximately $1.0 million. Accordingly, all operating results from continuing operations exclude the results for Agera which are presented as discontinued operations for all prior year numbers.

The financial results of Agera are classified as discontinued operations in the accompanying Consolidated Statement of Operations. Summary financial information related to discontinued operations is as follows:

	For the three months ended September 30, 2012		For the nine months ended September 30, 2012
Product sales	$	142	$	516
Cost of sales		65		275
Gross profit		77		241
Operating income	$	20	$	27
Net income (loss)	$	11	$	(2	)

In addition, there are other minimal costs from the Company’s Switzerland subsidiary which are classified as discontinued operations.